Screener
Rhythm Pharmaceuticals, Inc. RYTM Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value: 9,850,000 shares authorized; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value: 120,000,000 shares authorized; 68,445,084 and 67,205,321 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 69 | 67 |
| Additional paid-in capital | 1,529,909 | 1,491,675 |
| Accumulated other comprehensive income (loss) | 444 | (796) |
| Accumulated deficit | (1,407,516) | (1,351,877) |
| Total stockholders’ equity | 122,906 | 139,069 |
| Total liabilities, convertible preferred stock and stockholders’ equity | $442,316 | $480,196 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s retained earnings?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported retained earnings of -$1.41B in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s retained earnings changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s retained earnings decreased by 16.8% year-over-year, from -$1.2B to -$1.41B.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s retained earnings has grown at a 24.1% compound annual growth rate (CAGR), from -$459.33M to -$1.35B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude